Medication info
Mikartelmi Tablet 40 mg (Telmisartan)

Mikartelmi Tablet 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
White or off-white oval tablet
Packaging
30 tablets (10 tablets/PTP packaging x 3)
Approval status
Active

MFDS item code 201502262 · Approved 2015.04.15 · Insurance code 644102640

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular diseases (including myocardial infarction and stroke)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. This medicine provides an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular diseases (including myocardial infarction and stroke)

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • clinical evidence of high-risk diabetes with end-organ damage
View approved original text

This medication is primarily used for the treatment of essential hypertension. It also reduces the risk of cardiovascular diseases such as coronary artery disease, peripheral artery disease, and stroke in patients aged 55 and older who are at high risk, helping to lower the risk of myocardial infarction, stroke, and mortality due to cardiovascular diseases. It is especially recommended as an alternative treatment for patients who cannot use ACE inhibitors. It is used to improve cardiovascular health and reduce the overall risk of cardiovascular diseases.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. This medicine provides an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can pose serious risks, particularly to the fetus and newborn if used during pregnancy, so it must be discontinued immediately once pregnancy is confirmed. This medication should not be used by individuals who have had allergic reactions to this drug or its ingredients, pregnant or nursing women, patients with severe liver dysfunction or bile duct obstruction, patients with hereditary angioedema, and patients with diabetes or severe kidney impairment. Elderly patients, patients with hyperkalemia, those with mild to moderate liver dysfunction, patients with heart valve disease, patients with cardiovascular diseases, gastrointestinal disease patients, patients with renal artery hypertension, and those with severe kidney impairment should use this drug cautiously. Various side effects such as infections, anemia, hypersensitivity reactions, hyperkalemia, hypoglycemia, dizziness, blood pressure drop, breathing difficulties, liver dysfunction, rashes, myalgia, and kidney impairment may occur during the use of this medication, so symptoms should be closely monitored. Especially severe adverse reactions such as angioedema, hyperkalemia, renal dysfunction, shock, liver dysfunction, interstitial pneumonia, and rhabdomyolysis may occur, so consult your doctor immediately if any unusual symptoms appear. Patients with kidney impairment or those who have had a kidney transplant should have potassium and creatinine levels checked regularly, and patients with sodium depletion or low blood volume may be at risk of hypotension, so caution is necessary. Combined use with other antihypertensive drugs may increase the blood pressure-lowering effect, so it should be taken according to a doctor's instructions, and it is essential to inform the doctor about any concomitant medications, as there may be drug interactions. Women who are pregnant or planning to become pregnant should not use this medication, and nursing mothers should avoid it or stop breastfeeding. Safety in children under 18 years of age has not been established, so its use is not recommended. In case of overdose, symptoms like hypotension, dizziness, and acute kidney failure may occur, so dosage should be adhered to strictly, and if any unusual symptoms occur, consult healthcare professionals immediately. When storing, keep this medication in a tightly sealed container away from children's reach, and open the packaging only right before use, avoiding transfer to other containers. This medication may cause fainting or dizziness while driving or operating machinery, so caution is advised.

Side effects

  • Upper respiratory tract infections
  • pharyngitis
  • sinusitis
  • urinary tract infections
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 81 more
  • anaphylactic reactions
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • liver dysfunction
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased blood creatinine
  • increased uric acid in blood
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • headache
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial swelling
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • shock
  • loss of consciousness
  • jaundice
  • anaphylaxis-like symptoms
  • interstitial pneumonia
  • rhabdomyolysis
  • palpitations
  • fatigue
  • nausea
  • inadequate effect
  • dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is susceptible to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius. This will help preserve the medication's efficacy for a longer period.

Appearance and packaging

Appearance

White or off-white oval tablet

Package unit

30 tablets (10 tablets/PTP packaging x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.